Ovid Therapeutics Inc.

New Filing
CIK: 0001636651·Other Technology·DELAWARE·Filed: Mar 18, 2015
Total Offering

$5,060,000

Amount Sold

$5,060,000

Investors

5

First Sale

Oct 10, 2014

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2014
Non-Accredited Investors
No

Related Persons

NameRole
Matthew J. During
Related Person
Jeremy M. Levin
Related Person
Mark Feldberg
Related Person

Company

Ovid Therapeutics Inc.

205 EAST 42ND STREET

NEW YORK, NY, 10017

212-776-4381

SEC Filing

0001140361-15-012509

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Ovid Therapeutics Inc. Form D Filing — $5,060,000 | FilingFlow